市场调查报告书
商品编码
1518348
玻片染色设备市场:依产品、方法、应用和最终用户划分 - 到 2030 年的全球预测Slide Stainers Market by Product (Reagent Equipment) Technique (H&E, ISH, IHC, Hematology, Cytology) Application (Diagnosis, Research) End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2030 |
预计2030年全球玻片染色设备市场将达55.3亿美元,2023年至2030年复合年增长率为7.9%。
该报告在广泛的二级和一级研究以及对市场情景的详细分析后,对关键行业驱动因素、限制因素、课题和机会进行了分析。这项成长的推动因素包括慢性病负担增加、老年人口增加、玻片染色设备技术进步、个人化治疗需求增加、医疗支出增加、自动化需求增加等。然而,载玻片染色系统的高成本限制了该市场的成长。
此外,对自动玻片染色和诊断系统的需求不断增长以及新兴国家的成长机会预计将使该市场的参与者受益。然而,围绕自动玻片染色设备的担忧和缺乏熟练专业人员等课题正在严重影响市场成长。
(註:SWOT分析仅针对排名前5的公司)
Slide Stainers Market Size, Share, Forecast, & Trends Analysis by Product (Reagent [Stains, Mounting, Processing] Equipment) Technique (H&E, ISH, IHC) Application (Diagnosis, Research), and End User (Hospital, Pharmaceutical, Academic)-Global Forecast to 2030
The global slide stainers market is projected to reach $5.53 billion by 2030 at a CAGR of 7.9% from 2023 to 2030.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to rising geriatric population, coupled with the growing burden of chronic diseases, technological advancements in slide stainers, increasing need for personalized treatment, rising healthcare expenditure, increasing demand for automation in diagnostics & clinical research, and increasing cancer drug research. However, the high cost of slide straining systems restrains the growth of this market.
Furthermore, the increasing demand for automated slide staining and diagnostic systems, along with growth opportunities in emerging economies, is expected to benefit players in this market. However, challenges such as concerns surrounding automated slide stainers, and a shortage of skilled professionals are impacting market growth significantly.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2023). The key players operating in the global slide stainers market are Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Abcam plc. (U.K.), Siemens Healthineers (Germany), General Data Company, Inc. (U.S.), Biocare Medical LLC (U.S.), BioGenex (U.S.), PHC Holdings Corporation (Japan), and Hardy Diagnostics (U.S.).
Among all the products studied in this report, in 2023, the reagents & kits segment is expected to account for the largest share of the slide stainers market. The growing emphasis on personalized medicine requires the use of highly specialized reagents such as special stains, cytology stains, mounting reagents, and others essential for diagnostic tests. It has resulted in the development of novel and creative slide-staining reagents, such as multiplex staining reagents, which enable the simultaneous detection of numerous biomarkers on a single slide, contributing to the large share of this segment.
Among all the techniques studied in this report, in 2023, the hematoxylin and eosin (H&E) segment is expected to account for the larger share of the slide stainers market. Technological advancements in hematoxylin and eosin staining are contributing to developing improved and automated staining methods. This has made H&E staining more accessible to healthcare professionals and academics, increasing its adoption, use, and acceptance. Furthermore, the growing demand for hematoxylin and eosin for laboratory uses, and diagnostic tests contributes to this segment's largest share.
Among all the end users studied in this report, in 2023, the hospitals & diagnostic centers segment is expected to account for the largest share of the slide stainers market. Slide stainers are significant in hospitals & diagnostic centers, particularly in pathology, histology, and laboratory medicine. Their use is essential for accurately diagnosing, and treating a wide range of medical conditions. Slide stainers are essential tools in hospitals & diagnostic centers, enabling accurate & efficient pathological assessments, aiding in disease diagnosis and staging, and contributing to research & education in the medical field. Their automation and standardization capabilities enhance the quality of patient care, and scientific discoveries.
An in-depth analysis of the geographical scenario of the global slide stainers market provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa), along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the slide stainers market. In 2023, the U.S. is expected to account for the largest share of the slide stainers market in North America. The large share of this regional market is attributed to the presence of major slide stainers companies such as Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), and Agilent Technologies, Inc. (U.S.). The increasing geriatric population, coupled with the growing burden of chronic diseases, technological advancements in slide stainers, increasing need for personalized treatments, rising healthcare expenditure policies in the region.
Slide Stainers Market Assessment-by Product
Note: Other reagents and kits include solvents, buffers, diluents, solutions, and tissue softeners.
Slide Stainers Market Assessment-by Technique
Slide Stainers Market Assessment-by Application
Note: Other diseases include autoimmune diseases and hematological diseases.
Slide Stainers Market Assessment-by End Users
Slide Stainers Market Assessment-by Geography
(Note: SWOT analysis will be provided for only the top 5 companies.)